Pharmacologically active compounds in the environment and their chirality

被引:375
|
作者
Kasprzyk-Hordern, Barbara [1 ,2 ]
机构
[1] Univ Huddersfield, Dept Chem & Biol Sci, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England
[2] Univ Bath, Dept Chem, Fac Sci, Bath BA2 7AY, Avon, England
关键词
SOLID-PHASE EXTRACTION; PERSONAL CARE PRODUCTS; TANDEM MASS-SPECTROMETRY; WASTE-WATER TREATMENT; SEWAGE-TREATMENT PLANTS; ENDOCRINE-DISRUPTING COMPOUNDS; SEROTONIN REUPTAKE INHIBITORS; DIFFERENT THERAPEUTIC CLASSES; LIQUID-CHROMATOGRAPHY; ILLICIT DRUGS;
D O I
10.1039/c000408c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Pharmacologically active compounds including both legally used pharmaceuticals and illicit drugs are potent environmental contaminants. Extensive research has been undertaken over the recent years to understand their environmental fate and toxicity. The one very important phenomenon that has been overlooked by environmental researchers studying the fate of pharmacologically active compounds in the environment is their chirality. Chiral drugs can exist in the form of enantiomers, which have similar physicochemical properties but differ in their biological properties such as distribution, metabolism and excretion, as these processes (due to stereospecific interactions of enantiomers with biological systems) usually favour one enantiomer over the other. Additionally, due to different pharmacological activity, enantiomers of chiral drugs can differ in toxicity. Furthermore, degradation of chiral drugs during wastewater treatment and in the environment can be stereoselective and can lead to chiral products of varied toxicity. The distribution of different enantiomers of the same chiral drug in the aquatic environment and biota can also be stereoselective. Biological processes can lead to stereoselective enrichment or depletion of the enantiomeric composition of chiral drugs. As a result the very same drug might reveal different activity and toxicity and this will depend on its origin and exposure to several factors governing its fate in the environment. In this critical review a discussion of the importance of chirality of pharmacologically active compounds in the environmental context is undertaken and suggestions for directions in further research are made. Several groups of chiral drugs of major environmental relevance are discussed and their pharmacological action and disposition in the body is also outlined as it is a key factor in developing a full understanding of their environmental occurrence, fate and toxicity. This review will be of interest to environmental scientists, especially those interested in issues associated with environmental contamination with pharmacologically active compounds and chiral pollutants. As the review will outline current state of knowledge on chiral drugs, it will be of value to anyone interested in the phenomenon of chirality, chiral drugs, their stereoselective disposition in the body and environmental fate (212 references).
引用
收藏
页码:4466 / 4503
页数:38
相关论文
共 50 条
  • [21] CHIRALITY OF POLYVINYL COMPOUNDS .1. OPTICALLY-ACTIVE POLYVINYL COMPOUNDS WITH CHIRALITY IN MAIN CHAIN
    WULFF, G
    ZABROCKI, K
    HOHN, J
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1978, 17 (07): : 535 - 537
  • [22] MICROBIAL PRODUCTION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS OTHER THAN ANTIBIOTICS
    BRANNON, DR
    FULLER, RW
    LLOYDIA-THE JOURNAL OF NATURAL PRODUCTS, 1974, 37 (02): : 134 - 146
  • [23] Prospects of Using Pharmacologically Active Compounds for the Creation of Antimycobacterial Drugs
    A. V. Khrapova
    L. V. Saroyants
    M. Yu. Yushin
    A. S. Zukhairaeva
    A. V. Velikorodov
    Pharmaceutical Chemistry Journal, 2022, 55 : 1108 - 1114
  • [24] Pharmacologically active phenolic compounds from the bark of Mahonia aquifolium
    Wirth, C
    Wagner, H
    PHYTOMEDICINE, 1997, 4 (04) : 357 - 358
  • [25] THE INFLUENCE UPON THE EEG OF PHARMACOLOGICALLY ACTIVE COMPOUNDS OF CLINICAL INTEREST
    VERDEAUX, G
    MARTY, R
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1955, 7 (01): : 148 - 148
  • [26] The Pauson-Khand Reaction in the Synthesis of Pharmacologically Active Compounds
    Habermann, Joerg
    CURRENT ORGANIC CHEMISTRY, 2010, 14 (11) : 1139 - 1152
  • [27] New Approaches for the Discovery of Pharmacologically-Active Natural Compounds
    Medina-Franco, Jose L.
    BIOMOLECULES, 2019, 9 (03):
  • [28] Mechanochemical and Mechanoenzymatic Synthesis of Pharmacologically Active Compounds: A Green Perspective
    Perez-Venegas, Mario
    Juaristi, Eusebio
    ACS SUSTAINABLE CHEMISTRY & ENGINEERING, 2020, 8 (24) : 8881 - 8893
  • [29] MICROBIAL PRODUCTION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS OTHER THAN ANTIBIOTICS
    BRANNON, DR
    LLOYDIA-THE JOURNAL OF NATURAL PRODUCTS, 1973, 36 (04): : 430 - 430
  • [30] The Search for Pharmacologically Active Compounds Among the 2-Dialkylaminobenzimidazoles
    Zhukovskaya, O. N.
    Anisimova, V. A.
    Spasov, A. A.
    Yakovlev, D. S.
    Gurova, N. A.
    Kucheryavenko, A. F.
    Salaznikova, O. A.
    Kuznetsova, V. A.
    Mal'tsev, D. V.
    Brigadirova, A. A.
    Morkovina, Ya. V.
    Solov'eva, O. A.
    Gurova, V. V.
    Reznikov, E. V.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2017, 51 (03) : 182 - 186